Zhou Z, Liang H, Yang R, Yang Y, Dong J, Di Y, et al
This dose-increase guide for GLP-1s will tell you everything you need to knowconsider it your personal user manual for escalating doses of GLP-1 therapies
But we've been watching the GLP-1 space and just always thinking about what new effective treatments and solutions we can launch for our patients," Melynda Barnes, M.D., Ro's chief medical officer, said during an interview on the sidelines of the ViVE Conference in Nashville, Tennessee
The treatment landscape for CKM changed dramatically when agents from several medication classes, originally developed as glucose-lowering therapies, were recognized to reduce the risk of multiple components of CKM syndrome